GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lavipharm SA (FRA:BXA0) » Definitions » Price-to-Free-Cash-Flow

Lavipharm (FRA:BXA0) Price-to-Free-Cash-Flow : N/A (As of May. 23, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Lavipharm Price-to-Free-Cash-Flow?

As of today (2025-05-23), Lavipharm's share price is €0.72. Lavipharm's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.02. Hence, Lavipharm's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Lavipharm's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 7 years, Lavipharm's highest Price-to-Free-Cash-Flow Ratio was 53.70. The lowest was 2.66. And the median was 17.13.

FRA:BXA0's Price-to-Free-Cash-Flow is not ranked *
in the Drug Manufacturers industry.
Industry Median: 23.76
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Lavipharm's Free Cash Flow per Share for the six months ended in Jun. 2024 was €0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was €-0.02.

During the past 7 years, Lavipharm's highest 3-Year average Free Cash Flow per Share Growth Rate was 83.10% per year. The lowest was 19.50% per year. And the median was 51.30% per year.


Lavipharm Price-to-Free-Cash-Flow Historical Data

The historical data trend for Lavipharm's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lavipharm Price-to-Free-Cash-Flow Chart

Lavipharm Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial 23.63 17.50 12.56 - -

Lavipharm Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Lavipharm's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Lavipharm's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lavipharm's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lavipharm's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Lavipharm's Price-to-Free-Cash-Flow falls into.


;
;

Lavipharm Price-to-Free-Cash-Flow Calculation

Lavipharm's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.72/-0.024
=N/A

Lavipharm's Share Price of today is €0.72.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lavipharm's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.02.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Lavipharm  (FRA:BXA0) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Lavipharm Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Lavipharm's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Lavipharm Business Description

Traded in Other Exchanges
Address
Agias Marinas Street, PO Box 59, Peania Attica, GRC, 19002
Lavipharm SA develops, manufactures, markets and distributes pharmaceutical, cosmetic and consumer health products in Greece and internationally. The company's product portfolio includes safe and effective therapeutic solutions that meet consumer' needs for health and wellbeing. Its main product categories are Cardiology, Oncology, Urology, Neurology, Psychiatry, General Medicine, Self- Treatment and Dermocosmetic care.

Lavipharm Headlines

No Headlines